Note: Ingredients listed on restricted chemical lists
EC/CAS
201-114-5/78-40-0
Name of the chemical
Phosphoric acid, triethyl ester, TEP
Concentration
2.5-<5%
EC/CAS
201-114-5/111-46-6
Name of the chemical
diethyleneglycol
Concentration
1-<2.5%
EC/CAS
945-730-9/77-99-6
Name of the chemical
1,1,1-trimethylolpropane
Concentration
1-<2.5%
EC/CAS
203-872-2
Name of the chemical
Diethylene glycol (DEG); 2,2′-oxydiethanol for traces level, see Annex III
Concentration
1-<2.5%
General Information
Version
2,2 - Replaces version 2,1
Revision date
2024-03-18
Product name
WEVOPUR 552 FL
1.2.1 Relevant identified uses
Resin/Polyol components for the production of polyurethanes
Emergency telephone
+44 870 243 2241, +49 30 19240
Icons in SDS
Company Information
company name
WEVO-CHEMIE GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@wevo-chemie.de, MSDS@wevo-chemie.de
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
GB CLP Regulation Skin Sens. 1; H317 Full text of hazard statements: see SECTION 16.
Hazard statements
see SECTION 16 H317 May cause an allergic skin reaction.
2.2 Label elements
GB CLP Regulation
Hazardous Ingredients
Fatty acids, C18-unsaturated, trimers, compounds with oleylamine Fatty acids, tall oil, compounds with oleylamine
Signal word
Warning
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection. P302+P352 IF ON SKIN: Wash with plenty of soap and water. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P362+P364 Take off contaminated clothing and wash it before reuse. P501 Dispose of contents/container to an appropriate recycling or disposal facility.
2.3 Other hazards
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
